|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/155 | |||
| A61K 31/485 | |||
| A61P 29/00 | |||
| A61P 43/00 | |||
| A61K 31/135 | |||
| A61K 31/439 | |||
| A61K 31/195 | |||
| A61K 31/55 | |||
| C07D 217/04 |
| (11) | Number of the document | 2349241 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09740597.1 |
| Date of filing the European patent application | 2009-10-16 | |
| (97) | Date of publication of the European application | 2011-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/061068 |
| Date | 2009-10-16 |
| (87) | Number | WO 2010/045599 |
| Date | 2010-04-22 |
| (30) | Number | Date | Country code |
| 106400 P | 2008-10-17 | US |
| (72) |
JENKINS, Thomas, E., US
SEROOGY, Julie, D., US
WRAY, Jonathan, W., US
|
| (73) |
Signature Therapeutics, Inc.,
1731 Embarcadero Road, Suite 200, Palo Alto, CA 94303,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS WITH ATTENUATED RELEASE OF PHENOLIC OPIOIDS |
| PHARMACEUTICAL COMPOSITIONS WITH ATTENUATED RELEASE OF PHENOLIC OPIOIDS |